# Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

> **NCT00275119** · PHASE2 · UNKNOWN · sponsor: **GERCOR - Multidisciplinary Oncology Cooperative Group**

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** oxaliplatin
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00275119
- **Lead sponsor:** GERCOR - Multidisciplinary Oncology Cooperative Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00275119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00275119, "Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00275119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*